Stock Market Reviews

COSM (Cosmos Health Inc.) News

Get the latest news, insights, and market updates on COSM (Cosmos Health Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy
  CHICAGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the initiation of a new research and development program leveraging nanotechnology to enhance the effectiveness of phytochemical constituents used in its dietary supplement formulas. This new initiative builds upon the proprietary know-how developed during the creation of CCX Hydrogel, a breakthrough platform
  Oct 31, 2025 - $COSM
• Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement
  CHICAGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that on October 15, 2025, it received written notice (the ”Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share (the “Listing Rule”). In the Notice, Nasdaq stated that
  Oct 16, 2025 - $COSM
• Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility
  CHICAGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has purchased an additional $500,000 worth of Ethereum (ETH), bringing its total investment in ETH to $1.5 million. This acquisition was executed pursuant to Cosmos Health’s previously announced $300 million digital assets facility, which is part of the Company’s broader strategic initiative to divers
  Oct 10, 2025 - $COSM
• Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units
  CHICAGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its subsidiary, SkyPharm S.A., has entered into an exclusive distribution agreement, dated as of September 28, 2025, with Diyar United for the marketing and sale of its Sky Premium Life® line of nutraceuticals in Kuwait. Diyar United is a respected distributor in Kuwait with extensive healthcare experien
  Oct 3, 2025 - $COSM
• Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
  CHICAGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the commencement of its U.S. operations with the launch of its proprietary Sky Premium Life food supplements brand. All Sky Premium Life products sold in the United States are manufactured locally in GMP-certified, FDA-registered, and UL-audited U.S. facilities, underscoring the Company’s commitment to regul
  Sep 22, 2025 - $COSM
• Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
  CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Sky Pharm SA, signed a distribution agreement (the “Agreement”) with Scientific Pharmacy LLC (“Scientific Pharmacy”) for its Sky Premium Life food supplement products in Oman. Scientific Pharmacy, the retail and wholesale arm of Planet Pharmacies in Oman, is a leading health
  Sep 11, 2025 - $COSM
• Cosmos Health secures $300M financing facility to launch Ethereum strategy
  Cosmos Health (COSM) entered into a securities purchase agreement with a U.S.-based institutional investor for the issuance of up to $300M in senior secured convertible promissory notes, subject to the satisfaction or waiver of certain conditions, to support the launch of its Ethereum digital asset treasury reserve strategy. Key Highlights: Strategic accumulation of ETH to enhance long-term shareholder value through increasing ETH-per-share; ETH assets will be custodied and staked through instit
  Aug 7, 2025 - $COSM
• A US$10m Market Cap Boost Pleasing ToCosmos Health Insiders
  Last week, Cosmos Health Inc. ( NASDAQ:COSM ) insiders, who had purchased shares in the previous 12 months were...
  Jul 30, 2025 - $COSM
• Cosmos Health enters U.S. market with DolCas Biotech agreement
  Cosmos Health (COSM) announced its entry into the U.S. market and the launch of U.S.-based manufacturing through a strategic agreement with DolCas Biotech LLC, a New Jersey-based developer and manufacturer of clinically studied nutraceutical ingredients. Cosmos Health is set to commence production in the United States at GMP-certified facilities, marking a significant milestone in the company’s operational expansion. This move not only mitigates tariff exposure and cross-border logistical risks
  Jun 25, 2025 - $COSM
• Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech
  CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today its entry into the U.S. market and the launch of U.S.-based manufacturing through a strategic agreement with DolCas Biotech LLC (
  Jun 24, 2025 - $COSM